Assessing the role of colonic and other anatomical sites uptake by [ 18 F]FDG-PET/CT and immune-inflammatory peripheral blood indexes in patients with advanced non-small cell lung cancer treated with first-line immune checkpoint inhibitors.

Alessio RizzoOrnella CantaleAndrea MogaveroLucia GarettoManuela RaccaTiziana VenesioShobana AnpalakhanSilvia NovelloVanesa GregorcGiuseppe Luigi Banna

Published in: Thoracic cancer (2023)

deserves further investigation.

Keyphrases

advanced non small cell lung cancer
peripheral blood
epidermal growth factor receptor
oxidative stress
ulcerative colitis
tyrosine kinase
newly diagnosed